Oslo, 31 August 2026
Reference is made to the stock exchange announcement by Nykode Therapeutics ASA
(the "Company") on 27 August 2026 regarding the successful private placement of
65,000,000 new shares in the Company (the "Offer Shares") at a subscription
price of NOK 4.40 per Offer Share (the "Private Placement").
The share capital increase pertaining to the Private Placement has today been
registered with the Norwegian Register of Business Enterprises. Following the
registration, the share capital of the Company is NOK 3,915,464.44, divided into
391,546,444 shares, each with a nominal value of NOK 0.01.
The Offer Shares are tradable on Euronext Oslo Børs as of today.
Oslo Børs as of today. \